Hangzhou Diagens Biotechnology Co., Ltd. (HKG:2526)
271.00
+1.80 (0.67%)
At close: Apr 29, 2026
HKG:2526 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
| Cash & Equivalents | 12.87 | 17.1 | 20.42 |
| Short-Term Investments | 21.59 | 25 | 24.12 |
| Trading Asset Securities | 11 | 16.5 | 39.99 |
| Cash & Short-Term Investments | 45.46 | 58.6 | 84.53 |
| Cash Growth | -22.42% | -30.67% | - |
| Accounts Receivable | 53.02 | 32.4 | 6.19 |
| Other Receivables | 0.59 | 0.12 | 3.96 |
| Receivables | 53.61 | 32.52 | 10.15 |
| Inventory | 22.66 | 22.86 | 27.06 |
| Prepaid Expenses | 0.81 | 0.35 | 1.04 |
| Other Current Assets | 13.41 | 8 | 7.83 |
| Total Current Assets | 135.95 | 122.33 | 130.6 |
| Property, Plant & Equipment | 29.32 | 37.24 | 35.04 |
| Long-Term Investments | 42.93 | 42.9 | 43 |
| Other Intangible Assets | 1.66 | 1.1 | 1.63 |
| Long-Term Accounts Receivable | 0.16 | 0.04 | - |
| Other Long-Term Assets | 5.56 | 8.86 | 10.82 |
| Total Assets | 215.58 | 212.47 | 221.09 |
| Accounts Payable | 17.33 | 7.43 | 3.24 |
| Accrued Expenses | 10.76 | 6.5 | 11.06 |
| Current Portion of Long-Term Debt | - | 10 | - |
| Current Portion of Leases | 1.47 | 2.84 | 3.39 |
| Current Income Taxes Payable | 0.01 | - | - |
| Current Unearned Revenue | 0.57 | 0.99 | 3.7 |
| Other Current Liabilities | 15.02 | 4.1 | 2.3 |
| Total Current Liabilities | 45.16 | 31.85 | 23.69 |
| Long-Term Leases | 4.45 | 6.28 | 1.11 |
| Long-Term Deferred Tax Liabilities | 0.25 | 0.16 | 0.08 |
| Other Long-Term Liabilities | - | - | 281.83 |
| Total Liabilities | 49.85 | 38.29 | 306.71 |
| Common Stock | 80.88 | 20.88 | 20.88 |
| Retained Earnings | - | -272.08 | -228.7 |
| Comprehensive Income & Other | 84.85 | 425.38 | 122.2 |
| Shareholders' Equity | 165.73 | 174.18 | -85.62 |
| Total Liabilities & Equity | 215.58 | 212.47 | 221.09 |
| Total Debt | 5.92 | 19.12 | 4.5 |
| Net Cash (Debt) | 39.54 | 39.48 | 80.03 |
| Net Cash Growth | 0.16% | -50.67% | - |
| Net Cash Per Share | 0.49 | 0.50 | 1.05 |
| Filing Date Shares Outstanding | 80.88 | 80.88 | 76.18 |
| Total Common Shares Outstanding | 80.88 | 80.88 | 76.18 |
| Working Capital | 90.8 | 90.48 | 106.91 |
| Book Value Per Share | 2.05 | 2.15 | -1.12 |
| Tangible Book Value | 164.06 | 173.08 | -87.24 |
| Tangible Book Value Per Share | 2.03 | 2.14 | -1.15 |
| Machinery | - | 31.79 | 24.34 |
| Leasehold Improvements | - | 16.01 | 16.76 |
Source: S&P Capital IQ. Standard template. Financial Sources.